Patrick “Alan” Lennon, PhD, FACMG, Completes Term as President of the Cancer Genomics Consortium at the CGC Annual Meeting in Nashville, TN

After serving as President-Elect/Scientific Program Chair for the annual meeting held in Denver, CO in 2017, Alan Lennon, PhD, FACMG took the helm as President of the Cancer Genomics Consortium.  The Cancer Genomics Consortium (CGC) is a non-profit organization formed in 2009 by a group of clinical cytogeneticists, molecular geneticists, and molecular pathologists who are interested in applying whole genome and other genetic technologies to cancer diagnosis and cancer research.  During his presidential term, working groups which Lennon fostered back in 2016 to publish evidence-based reviews on assessing whole genome copy number aberrations and copy neutral loss of heterozygosity as best practice in a variety of cancers saw several works accepted for publication. Over 270 cancer geneticists from 7 countries converged on the annual meeting in Nashville, TN, August 5 – 8. The 2018 Annual Meeting was the largest meeting to date and was supported by the largest corporate sponsorship to date. Lennon’s presidential term culminated at the annual meeting, although he serves two more years on the Board of Directors.

www.cancergenomics.org

Christopher Coldren PhD Co-Authors AMP Journal of Molecular Diagnostic Article

Brentwood, TN – (Wednesday, March 7, 2018) – PathGroup, a premier provider of anatomic, clinical and molecular pathology laboratory services, is pleased to announce that Christopher Coldren, PhD has co-authored an evidence based guideline published in the Journal of Molecular Diagnostics (Nov. 2017) entitled “Standards and Guidelines for Validating Next-Generation Sequencing Bioinformatics Pipelines.”

To read the full release, CLICK HERE

Pranil K. Chandra, DO to Present at 9th Annual Personalized & Precision Medicine Conference

Brentwood, TN – (Thursday, October 12, 2017) – PathGroup, one of the largest private providers of pathology and laboratory services in the Unites States, is pleased to announce that that Dr. Pranil K. Chandra will present at the 9th Annual Personalized and Precision Medicine Conference held October 16 – 17, 2017 in Orlando, Florida. Dr. Chandra currently serves as Vice President and Chief Medical Officer of Genomic and Clinical Pathology.

To see the full release, please CLICK HERE

Sandeep Mukherjee, Ph.D., to Present at Infectious Diseases Society for Obstetrics and Gynecology (IDSOG) Annual Meeting

Brentwood, TN – (Thursday, August 10, 2017) – PathGroup, one of the largest private providers of pathology and laboratory services in the Unites States, is pleased to announce that that Dr. Sandeep Mukherjee will present a poster abstract entitled “Prevalence of Mycoplasma genitalium in a Screening Population” at the Infectious Diseases Society of Obstetrics and Gynecology (IDSOG) Annual Meeting held August 10-12, 2017 in Park City, Utah.

To see the full release, please click HERE

Lennon, Chandra and Olds to Present at Cancer Genomics Consortium 2017 Summer Meeting

Brentwood, TN – (Monday, August 7, 2017) – PathGroup is pleased to announce that Alan Lennon, Ph.D., FACMG, is serving as the current President-Elect for the Cancer Genomics Consortium. He is also serving as the 2017 Scientific Committee Chair for the 2017 Summer Meeting held August 7- 9, 2017 in Denver, Colorado.  Dr. Lennon currently serves as the Senior Scientific Director, Clinical Cytogenetics, FISH and Microarray Services for PathGroup.

To see the full release, please click HERE

Pranil K. Chandra, DO to Serve on Association for Molecular Pathology (AMP) Solid Tumors Practice Committee

Brentwood, TN – (Thursday, August 3, 2017) – PathGroup, one of the largest private providers of pathology and laboratory services in the Unites States, is pleased to announce that that Dr. Pranil K. Chandra has been selected to serve a two-year term on the Solid Tumors Clinical Practice Committee for the Association for Molecular Pathology (AMP).

To read the full release, please click HERE

PathGroup’s Pranil K. Chandra, DO, FCAP, FASCP to Speak at 2017 Molecular Medicine Tri-Conference

Brentwood, TN – (Thursday, February 16, 2017) – PathGroup, one of the largest private providers of pathology and laboratory services in the Unites States, is pleased to announce that Pranil K. Chandra, DO, FCAP, FASCP,  Vice President and Chief Medical Officer and Medical Director,  Genomic and Clinical Pathology Services at PathGroup, will speak at the 2017 Molecular Medicine Tri-Conference  in San Francisco, CA on Monday, February 20, 2017.

Dr. Chandra’s session “Garnering Payer Support for Genomic Profiling by Demonstrating Clinical Utility” will review PathGroup’s experience with certain payers in garnering appropriate reimbursement for genomic profiling. In addition, he will review how to demonstrate clinical utility through illustrative examples highlighting diagnostic, prognostic, and/or therapeutic utility across hematologic and solid tumor malignancies.

For more information on the 2017 Molecular Medicine Tri-Conference please visit, http://www.triconference.com